September 24th, 2013
Study Raises Questions About Digoxin Use Today
Larry Husten, PHD
Digoxin is one of the oldest medicines in the cardiovascular arsenal. When William Withering identified it as the active ingredient in the foxglove plant more than 200 years ago, he was only codifying a longstanding folk remedy for heart failure, or “dropsy” as it was known then. Digoxin fully entered the modern era with the publication […]
March 21st, 2013
DIGging In: Three Reasons Why the Recent Digoxin Study Is Not Relevant to Readmission
Harlan M. Krumholz, MD, SM
The evidence is just not compelling that this this drug would reduce hospital readmissions
NEJM Journal Watch — Recent Cardiology Articles- Self-Expanding Supraannular Valve vs. Balloon-Expandable Valve in TAVR for Small Aortic Annulus
- A New TAVR Prosthesis for Aortic Regurgitation Shows Promise
- Aprocitentan, a Newly Approved Drug for Resistant Hypertension
- Preventive PCI of Vulnerable Plaques Linked to Fewer Cardiac Events
- News from the ACC Scientific Session 2024